ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 106 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.08 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $8,723,000 | -75.3% | 3,983,025 | -32.4% | 0.31% | -76.9% |
| Q1 2019 | $35,302,000 | -18.9% | 5,893,416 | 0.0% | 1.35% | -22.3% |
| Q4 2018 | $43,552,000 | -3.0% | 5,893,416 | +90.5% | 1.74% | +8.3% |
| Q3 2018 | $44,916,000 | -18.1% | 3,093,416 | +12.7% | 1.61% | -16.5% |
| Q2 2018 | $54,832,000 | +14.0% | 2,745,705 | 0.0% | 1.93% | +15.5% |
| Q1 2018 | $48,105,000 | -12.7% | 2,745,705 | +22.9% | 1.67% | -23.1% |
| Q4 2017 | $55,076,000 | +35.2% | 2,233,416 | +41.5% | 2.17% | +18.1% |
| Q3 2017 | $40,726,000 | +300.5% | 1,577,927 | +320.8% | 1.84% | +238.6% |
| Q2 2017 | $10,170,000 | -9.1% | 375,000 | 0.0% | 0.54% | +25.8% |
| Q1 2017 | $11,183,000 | +9.9% | 375,000 | 0.0% | 0.43% | +2.9% |
| Q4 2016 | $10,178,000 | +242.6% | 375,000 | +223.3% | 0.42% | +203.6% |
| Q3 2016 | $2,971,000 | – | 116,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 1,769,785 | $1,911,000 | 0.69% |
| Telemetry Investments, L.L.C. | 214,593 | $232,000 | 0.67% |
| Aisling Capital Management LP | 634,455 | $685,000 | 0.36% |
| Broadfin Capital, LLC | 1,620,000 | $1,750,000 | 0.32% |
| MFN Partners Management, LP | 1,500,000 | $1,620,000 | 0.24% |
| Sofinnova Investments, Inc. | 1,911,573 | $2,064,000 | 0.19% |
| Rock Springs Capital Management LP | 2,974,754 | $3,213,000 | 0.13% |
| Alambic Investment Management, L.P. | 150,636 | $163,000 | 0.12% |
| Cormorant Asset Management, LP | 250,000 | $270,000 | 0.02% |
| Man Group plc | 3,734,793 | $4,034,000 | 0.02% |